| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/03/1988 | US4741903 Novel enzyne derivatives |
| 05/03/1988 | US4741901 Preparation of polypeptides in vertebrate cell culture |
| 05/03/1988 | US4741900 Antibody-metal ion complexes |
| 05/03/1988 | US4741832 Dialysis |
| 05/03/1988 | CA1236018A1 Attenuated smallpox vaccine strain |
| 05/03/1988 | CA1236017A1 Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
| 05/03/1988 | CA1236016A1 Glycosidic linkage related antigen, process for producing the same and anticancer agent containing the same as effective component |
| 04/27/1988 | EP0265384A2 Monoclonal antibodies to a colony stimulating factor |
| 04/27/1988 | EP0264979A1 New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines |
| 04/27/1988 | CN87106696A Proteins and process for preparing them, adn sequence, antibodys and their application, poxvirus, transformed or infected cells used as pharmaceutical comg |
| 04/26/1988 | US4740589 Capsular polysaccharide metal complex vaccines |
| 04/26/1988 | US4740585 Synthetic vaccine against urinary infections |
| 04/26/1988 | US4740468 Concentrating immunochemical test device and method |
| 04/26/1988 | US4740467 Using monoclonal antibodies specific for treponema bacterial pathogens |
| 04/26/1988 | US4740457 Method of diagnosis |
| 04/26/1988 | US4740371 Desensitization by administering allergen in mixture with an antibody thereto |
| 04/26/1988 | US4740304 Composition for use in a twophase or multiphase system |
| 04/26/1988 | CA1235660A1 Cell membrane proteins, compositions containing them and a procedure for their preparation |
| 04/26/1988 | CA1235656A1 Process for differentiating the origin of particles in urine |
| 04/21/1988 | WO1988002757A1 Hybrid proteins or polypeptides |
| 04/21/1988 | WO1988002754A1 New peptides and applications thereof |
| 04/21/1988 | WO1988002634A1 Vaccine for use in the therapeutic treatment of hsv |
| 04/21/1988 | WO1988002631A1 IgE-INDUCED REGULANT (EIR) COMPOSITIONS |
| 04/21/1988 | WO1988002594A2 Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof |
| 04/20/1988 | EP0264219A2 Receptors for immune complexes, their methods of production and assay methods using them |
| 04/20/1988 | EP0264150A1 Microorganisms comprising pili as carrier proteins, isolated pili, method for excreting proteins using these pili and their use |
| 04/20/1988 | EP0263934A1 Method for separation and purification of biopolymers by affinity chromatography |
| 04/20/1988 | EP0263933A1 A cDNA coding for carcinoembryonic antigen |
| 04/20/1988 | EP0263847A1 Methods and compositions relating to regression-associated antigens |
| 04/20/1988 | CN87104886A Biologic response modifier |
| 04/20/1988 | CN87102945A Pre-s gene coded peptide hepatilis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/19/1988 | US4738926 Method for purification of HBs antigen |
| 04/19/1988 | US4738846 Synthetic |
| 04/19/1988 | US4738843 Anti-tumor substance of immunoglobulin and melphalan and process for producing the same |
| 04/19/1988 | US4738773 Free-flowing flow path; helical separating member and |
| 04/14/1988 | DE3644924A1 Structural phosphoprotein (pp 150) of human cytomegalovirus, its preparation and use |
| 04/13/1988 | EP0263761A2 Non-A, non-B, hepatitis antigen |
| 04/13/1988 | EP0263655A2 Novel peptides having antiallergic activity |
| 04/13/1988 | EP0263591A2 Recombinant vaccinia virus |
| 04/13/1988 | EP0263528A2 Live salmonella vaccine with a host species-adapted attenuation and an anti-epidemic potential |
| 04/13/1988 | EP0263361A2 Vaccine against hepatitis A |
| 04/13/1988 | EP0263328A1 Tissue-specific viral vectors on the basis of LPV, and their use |
| 04/13/1988 | EP0263207A1 Virus vaccine |
| 04/13/1988 | EP0263135A1 Antiparatypical antibodies, their use for detecting and treating auto-immune diseases |
| 04/12/1988 | US4737579 Diagnosis, therapy |
| 04/12/1988 | US4737544 Biospecific polymers |
| 04/12/1988 | US4737363 Sheep foot rot |
| 04/07/1988 | WO1988002403A1 Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
| 04/07/1988 | WO1988002401A1 Recombinant pseudomanas exotoxin: construction of an active immunotoxin with low side effects |
| 04/07/1988 | WO1988002262A1 Biodegradable polymeric drug delivery system with adjuvant activity |
| 04/07/1988 | WO1988000974A3 Genes encoding antigens of m. leprae |
| 04/06/1988 | EP0263048A1 Process for culturing the virus of turkey Rhinotracheitis and vaccine prepared from the virus thus obtained |
| 04/06/1988 | EP0263046A1 Affinity enhancement immunological reagents for detection and killing of specific target cells |
| 04/06/1988 | EP0263025A2 Fractions containing antigens specific for herpes virus type 1 (HSV-1) and type 2 (HSV-2), method for isolating these fractions and diagnostic method specific for HSV-1 and/or HSV-2 using these fractions |
| 04/06/1988 | EP0262887A2 FeLV-infected feline cell line |
| 04/06/1988 | EP0262710A1 Use of a peptide for the preparation of compositions for the alleviation, treatment and diagnosis of autoimmune diseases, especially arthritic conditions, compounds related to said peptide, micro-organisms expressing said peptide or a compound related to said peptide, as well as pharmaceutical and diagnostic compositions and test kits |
| 04/06/1988 | EP0262571A2 Monoclonal antibodies against IFN-omega, process for preparing them and their use in the purification and detection of IFN-omega |
| 04/05/1988 | US4736019 Process for the separation of antifactor VIII:C antibodies, more particularly usable for the purification of the blood plasma of a type a hemophiliac |
| 04/05/1988 | US4736017 From purified gal-gal pilus proteins or fragments there of |
| 04/05/1988 | US4735896 Polypeptides |
| 04/05/1988 | US4735801 Novel non-reverting salmonella live vaccines |
| 04/05/1988 | US4735800 Vaccines against rift valley fever virus |
| 04/05/1988 | US4735799 Polypeptide |
| 04/05/1988 | CA1234756A1 Bioluminescent immunoassays |
| 03/30/1988 | EP0261940A2 Pseudorabies vaccines and DNA vectors for recombination with pox viruses |
| 03/30/1988 | EP0261671A2 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 03/30/1988 | EP0261493A2 Method for the determination of IgM and IgA immunoglobulins and reagents therefor |
| 03/30/1988 | EP0261233A1 Immortalized virus-specific tissue cells |
| 03/30/1988 | EP0261174A1 Diagnostic methods using soluble t cell surface molecules |
| 03/30/1988 | EP0261168A1 Feline infectious peritonitis vaccine |
| 03/29/1988 | US4734403 Membrane polysaccharides which are useful as immunostimulants |
| 03/29/1988 | US4734362 Process for purifying recombinant proteins, and products thereof |
| 03/29/1988 | US4734279 Synergistic |
| 03/24/1988 | WO1988002027A1 Genetically engineered vaccines for mycobacteria |
| 03/24/1988 | WO1988002026A1 Empty viral capsid vaccines |
| 03/24/1988 | WO1988001875A1 Immunomodulation |
| 03/24/1988 | WO1988001874A1 Method and vaccine for treatment of demyelinating diseases |
| 03/24/1988 | WO1988001873A1 Vaccine and method of preparation |
| 03/23/1988 | EP0260939A2 Molecules with antibody combining sites that exhibit catalytic properties |
| 03/23/1988 | EP0260779A2 Use of an immunostimulating medicament |
| 03/23/1988 | EP0260691A2 Immunotherapy for aids patients |
| 03/23/1988 | EP0260610A2 Monoclonal antibodies against human tumour necrotic factor (TNF), and their use |
| 03/22/1988 | US4732974 Metal ion labeling of carrier molecules |
| 03/22/1988 | US4732971 Synthetic vaccines for foot and mouth disease |
| 03/22/1988 | US4732864 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
| 03/22/1988 | US4732848 Antibodies |
| 03/22/1988 | US4732763 Active/passive immunization of the internal female reproductive organs |
| 03/22/1988 | US4732757 Prevention and treatment of rheumatoid arthritis |
| 03/22/1988 | CA1234363A1 Monoclonal antibodies to surface recognition structure of mature human t lymphocyte clone |
| 03/16/1988 | EP0260090A2 Expression of hepatitis b viral antigens from recombinant baculovirus vectors |
| 03/16/1988 | EP0259904A1 Advanced anticancer therapy and cytotoxic medicaments for its implementation |
| 03/16/1988 | EP0259893A2 Agents for removing advanced glycosylation endproducts |
| 03/16/1988 | EP0259807A2 Complement-dependent cytolytic anti-trichomonas vaginalis monoclonal antibody and use thereof in therapy and in diagnosis |
| 03/16/1988 | EP0259615A1 Human low affinity Fc epsilon-receptor, the isolation, the recombinant preparation and purification thereof |
| 03/16/1988 | EP0259585A1 Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof |
| 03/16/1988 | EP0259438A1 Methods and materials for treatment of rheumatoid arthritis |
| 03/15/1988 | US4731337 Fluorimetric immunological assay with magnetic particles |
| 03/15/1988 | US4731245 Mucocutaneous nymphonode syndrome |
| 03/15/1988 | US4731244 Monoclonal antibody therapy |
| 03/15/1988 | CA1234048A1 Process for the preparation of lyophilized, adsorbed polyvalent vaccines |